Skip to content

Clinical trials

Phase 2 Post-Acute COVID-19 Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Phase 2 Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20213
20225
202314
202411
202510
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting7
Active, not recruiting6
Enrolling by invitation2
Withdrawn2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kanecia Obie Zimmerman5
Duke University3
Icahn School of Medicine at Mount Sinai2
ImmunityBio, Inc.2
AIM ImmunoTech Inc.1
AgelessRx1
Bateman Horne Center1
Beth Israel Deaconess Medical Center1
BioVie Inc.1
Brigham and Women's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome47
COVID-1913
Fatigue3
Mental Fatigue3
Parasomnias3
Anosmia2
Cognitive Dysfunction2
Coronavirus Infections2
Disorders of Excessive Somnolence2
Infections2

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.